Peer-reviewedLicence not statedMédecine et Maladies Infectieuses Formation
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
Related
- Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatment
- Impact of two rounds of azithromycin mass drug administration on active trachoma and ocular Chlamydia trachomatis infection in Naoero
- A Transfusion-transmitted Chronic Hepatitis E Virus Infection after Allogeneic Bone Marrow Transplantation with Viral Clearance Following Immunosuppression Tapering
- Antibodies targeting phage fiber and nozzle proteins impair Acinetobacter baumannii phage therapy by blocking infection and promoting immune clearance
- Cervicovaginal lipid mediator profiles during high-risk HPV infection associated with subsequent viral clearance or persistence: an exploratory pilot study
BibTeX
@article{molina2026evidence,
title = {{No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection}},
author = {J.M. Molina and Constance Delaugerre and J. Le Goff and B. Mela-Lima and D. Ponscarme and L. Goldwirt and N. de Castro},
journal = {Médecine et Maladies Infectieuses Formation},
year = {2026},
month = oct,
doi = {10.1016/j.medmal.2020.03.006},
url = {https://hal.science/hal-05783466v1},
}
RIS
TY - JOUR
TI - No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
AU - J.M. Molina
AU - Constance Delaugerre
AU - J. Le Goff
AU - B. Mela-Lima
AU - D. Ponscarme
AU - L. Goldwirt
AU - N. de Castro
PY - 2026
DA - 2026/10/07
JO - Médecine et Maladies Infectieuses Formation
DO - 10.1016/j.medmal.2020.03.006
UR - https://hal.science/hal-05783466v1
SN - 2772-7432
SN - 2772-7432
ER -